Rapid Therapeutic Hires Pharmaceutical Industry Authority to Oversee Labs

Dallas, TX –  January 26, 2021 – Rapid Therapeutic Science Laboratories, Inc. (OTCPK: RTSL) an SEC fully-reporting, growth-oriented aerosol manufacturing company focused on employing Metered Dose Inhaler (MDI) technology to deliver non-psychoactive cannabinoid compounds, announced today that it has hired Dr. Duane Drinkwine, Ph.D., to oversee all laboratory operations for the Company.   Dr. Drinkwine […]

ALTAIR PROVIDES UPDATE ON LITHIUM EXTRACTION AND BATTERY RECYCLING TECHNOLOGY

Pittsburgh, PA – January 26, 2020 – Altair International Corp. (OTCPK: ATAO) (the “Company” or “Altair”) is pleased to provide an update on its previously announced partnership with St-Georges Eco-Mining Corp. (CSE: SX) (OTC: SXOOF) (FSE: 85G1) (“St-Georges”) a Canadian public company engaged in the development of new Lithium extraction technologies.   On December 1, […]

MOOVLY INCREASES STREAMING BANDWIDTH TO SUPPORT OVER 3 MILLION USERS

Vancouver, BC – January 26, 2021 – Moovly Media Inc. (TSX VENTURE: MVY) (OTCPK: MVVYF) (FRANKFURT: 0PV2) (“Moovly” or the “Company”) is pleased to announce an increase in bandwidth and enhanced support to its browser-based platform that now serves more than three million users, including more than 300 of the Fortune 500 companies, as well […]

Kubient Announces Engagement with Lake Street Capital Markets, LLC to Provide Merger and Acquisition Services

New York, NY – January 25, 2021 — Kubient (NasdaqCM: KBNT, KBNTW) (“Kubient” or the “Company”) , the cloud advertising marketplace that enables advertisers and publishers to reach, monetize and connect their audiences efficiently and effectively, today announced that it has engaged Lake Street Capital Markets, LLC (“Lake Street”), a research-powered investment bank focused on growth companies, […]

Investors Are Eating Up Plant-Based Investment Opportunities By the Truck Load

FN Media Group Presents Microsmallcap.com Market Commentary   New York, NY – January 25, 2021 – While the food industry has seen a steady shift towards offering more plant-based options to their product lines, 2020 was indeed a mega-year for plant-based investment. In just the first three months of 2020 alone, US plant-based protein investment […]

Consumers Continue Flocking to Immune-Boosting Supplements as Health Crisis Rage On

FN Media Group Presents Microsmallcap.com Market Commentary   New York, NY – January 25, 2021 – The health crisis has completely changed life as we know it and caused a significant shift in consumer demand for immune-boosting products, vitamins, and supplements. Now, due to growing awareness around heath, the wellness supplements market is projected to […]

Immunotherapy Using Immune-Checkpoint Inhibitors (ICI) Modulators Are Revolutionizing Oncology Industry

Palm Beach, FL – January 25, 2021 Ovarian cancer is one of the most deadly gynecologic malignancy across the globe, but new treatments are gaining increased efficacy while displaying reduced toxicity. Clinical trials abound. Immunotherapy using immune-checkpoint modulators has been revolutionizing the oncology field far beyond their remarkable clinical efficacy in some patients. It creates […]

Top Of Cannabis Industry Trends List Is The Race To Introduce Newer, Stronger Strains

Palm Beach, FL – January 25, 2021 – For the past several years the revenue projections for the global cannabis market have continued to rise at an extraordinary pace and the future looks even more impressive. More legalization has created more revenues and more competition for retail operators. In order to keep at the forefront […]

BioVaxys Announces Initiation of Cancer Vaccine EU Clinical Program, Completion of BVX-0320 Preclinical Program and Vaccine Platform Expansion

Vancouver, BC –  January 25, 2021 – BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTC: LMNGF) (“BioVaxys” or “Company”) is pleased to provide a corporate update on recent advancements of its vaccine platforms, viral diagnostic and corporate objectives for 2021. BioVaxys is pleased to announce that it has commenced the clinical development program for BVX-0918A, […]